Literature DB >> 11909894

A new antiepileptic drug.

S D Shorvon, K van Rijckevorsel.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11909894      PMCID： PMC1737842          DOI： 10.1136/jnnp.72.4.426

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  8 in total

1.  Expanding metabolism for total biosynthesis of the nonnatural amino acid L-homoalanine.

Authors:  Kechun Zhang; Han Li; Kwang Myung Cho; James C Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-23       Impact factor: 11.205

2.  The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.

Authors:  Cécile Droz-Perroteau; Caroline Dureau-Pournin; Hervé Vespignani; Cécile Marchal; Patrick Blin; Sylvie Blazejewski; Clothilde Pollet; Jérémy Jové; Philip Robinson; Nicholas Moore; Annie Fourrier-Réglat
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

Review 3.  Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy.

Authors:  Sima I Patel; Angela K Birnbaum; James C Cloyd; Ilo E Leppik
Journal:  CNS Drugs       Date:  2015-12       Impact factor: 5.749

4.  Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers.

Authors:  Margherita Strolin Benedetti; Rhys Whomsley; Jean-Marie Nicolas; Colin Young; Eugène Baltes
Journal:  Eur J Clin Pharmacol       Date:  2003-10-07       Impact factor: 2.953

Review 5.  Secondary Epileptogenesis: Common to See, but Possible to Treat?

Authors:  Yujia Shen; Yiwei Gong; Yeping Ruan; Zhong Chen; Cenglin Xu
Journal:  Front Neurol       Date:  2021-12-06       Impact factor: 4.003

6.  Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetam.

Authors:  Varun Sreenivasan; Arkadiusz Z Dudek
Journal:  Case Rep Oncol       Date:  2013-01-30

7.  Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register.

Authors:  Udo Carl Wieshmann; Gus A Baker
Journal:  BMJ Open       Date:  2013-03-19       Impact factor: 2.692

8.  Monotherapy for partial epilepsy: focus on levetiracetam.

Authors:  Antonio Gambardella; Angelo Labate; Eleonora Colosimo; Roberta Ambrosio; Aldo Quattrone
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.